Review





Similar Products

93
Thermo Fisher gene exp map1lc3b mm00782868 sh
Gene Exp Map1lc3b Mm00782868 Sh, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp map1lc3b mm00782868 sh/product/Thermo Fisher
Average 93 stars, based on 1 article reviews
gene exp map1lc3b mm00782868 sh - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

92
Boster Bio solutions
Solutions, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/solutions/product/Boster Bio
Average 92 stars, based on 1 article reviews
solutions - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

96
Thermo Fisher gene exp map1lc3b hs00797944 s1
Gene Exp Map1lc3b Hs00797944 S1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp map1lc3b hs00797944 s1/product/Thermo Fisher
Average 96 stars, based on 1 article reviews
gene exp map1lc3b hs00797944 s1 - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc rabbit monoclonal antibodies against map1lc3b lc3b
Rabbit Monoclonal Antibodies Against Map1lc3b Lc3b, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal antibodies against map1lc3b lc3b/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
rabbit monoclonal antibodies against map1lc3b lc3b - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

92
Novus Biologicals map1lc3b lc3b
Map1lc3b Lc3b, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/map1lc3b lc3b/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
map1lc3b lc3b - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc map1lc3b
Map1lc3b, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/map1lc3b/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
map1lc3b - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier

95
Novus Biologicals primary antibodies against lc3b map1lc3b
Primary Antibodies Against Lc3b Map1lc3b, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against lc3b map1lc3b/product/Novus Biologicals
Average 95 stars, based on 1 article reviews
primary antibodies against lc3b map1lc3b - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

94
Cusabio lc3b
(A) Diffuse/fibrillary strong PD-L1 expression in glioblastoma (IHC, x400). (B) Diffuse/fibrillary PD-L1 moderate expression in glioblastoma (IHC, x200). (C) Diffuse/fibrillary and cytoplasmic weak PD-L1 expression in glioblastoma (IHC, x400). (D) High <t>LC3B</t> cytoplasmic expression in glioblastoma (IHC, x400). (E) Low LC3B expression in glioblastoma (IHC, x200)
Lc3b, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lc3b/product/Cusabio
Average 94 stars, based on 1 article reviews
lc3b - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

Image Search Results


(A) Diffuse/fibrillary strong PD-L1 expression in glioblastoma (IHC, x400). (B) Diffuse/fibrillary PD-L1 moderate expression in glioblastoma (IHC, x200). (C) Diffuse/fibrillary and cytoplasmic weak PD-L1 expression in glioblastoma (IHC, x400). (D) High LC3B cytoplasmic expression in glioblastoma (IHC, x400). (E) Low LC3B expression in glioblastoma (IHC, x200)

Journal: Neurosurgical Review

Article Title: Dual biomarker role of PD-L1 and LC3B in glioblastoma: prognostic and therapeutic potential

doi: 10.1007/s10143-025-04050-7

Figure Lengend Snippet: (A) Diffuse/fibrillary strong PD-L1 expression in glioblastoma (IHC, x400). (B) Diffuse/fibrillary PD-L1 moderate expression in glioblastoma (IHC, x200). (C) Diffuse/fibrillary and cytoplasmic weak PD-L1 expression in glioblastoma (IHC, x400). (D) High LC3B cytoplasmic expression in glioblastoma (IHC, x400). (E) Low LC3B expression in glioblastoma (IHC, x200)

Article Snippet: The sections placed in an endogenous peroxide block for 15 min and For purpose of antigen retrieval for both PDL-1 & LC3B, sections were treated in microwave of (600 W) by immersion of the slides in citrate puffer solution (PH 7) for 20 min subsequently applied PD-L1 (mouse monoclonal antibodies, CUSABIO, Houston, USA, clone no.14D8C2, product code: CSB-MA878942A1m, 1: 200 [ ]) and LC3B (mouse monoclonal antibody, CUSABIO, Houston, USA, Clone No. 18F2, Product Code CSB-MA171423, a dilution of 1: 100 for 60 min, and then immunocomplexes were visualized with diaminobenzidine for 10 min and covered by a coverslip.

Techniques: Expressing

OS according to expression of each PD-L1& LC3B and PFS according to LC3B; ( A ) OS in patients with high PD-L1 expression= 8.07 ± 0.62(Mean±SE) with 95% C.I (6.85-9.281), moderate expression OS= 9.65 ± 1.00 with 95% C.I (7.68-11.62) and weak PD-L1 expression OS=23.14 ±1.26with 95%C.I (20.67-25.60). ( B ) OS in cases with high LC3B expression=9.88 ± 1.19 (Mean±SE) with 95%C.I (7.55-12.21), and in those with low expression =20.77 ± 1.42 with 95%C.I (17.99-23.56). ( C ) PFS in cases with High LC3B expression = 2.93 ± 0.33(Mean±S.E )with 95%C.I=2.27-3.58. PFS in cases with Low expression =8.47 ± 0.36 with 95%C.I =7.75-9.18

Journal: Neurosurgical Review

Article Title: Dual biomarker role of PD-L1 and LC3B in glioblastoma: prognostic and therapeutic potential

doi: 10.1007/s10143-025-04050-7

Figure Lengend Snippet: OS according to expression of each PD-L1& LC3B and PFS according to LC3B; ( A ) OS in patients with high PD-L1 expression= 8.07 ± 0.62(Mean±SE) with 95% C.I (6.85-9.281), moderate expression OS= 9.65 ± 1.00 with 95% C.I (7.68-11.62) and weak PD-L1 expression OS=23.14 ±1.26with 95%C.I (20.67-25.60). ( B ) OS in cases with high LC3B expression=9.88 ± 1.19 (Mean±SE) with 95%C.I (7.55-12.21), and in those with low expression =20.77 ± 1.42 with 95%C.I (17.99-23.56). ( C ) PFS in cases with High LC3B expression = 2.93 ± 0.33(Mean±S.E )with 95%C.I=2.27-3.58. PFS in cases with Low expression =8.47 ± 0.36 with 95%C.I =7.75-9.18

Article Snippet: The sections placed in an endogenous peroxide block for 15 min and For purpose of antigen retrieval for both PDL-1 & LC3B, sections were treated in microwave of (600 W) by immersion of the slides in citrate puffer solution (PH 7) for 20 min subsequently applied PD-L1 (mouse monoclonal antibodies, CUSABIO, Houston, USA, clone no.14D8C2, product code: CSB-MA878942A1m, 1: 200 [ ]) and LC3B (mouse monoclonal antibody, CUSABIO, Houston, USA, Clone No. 18F2, Product Code CSB-MA171423, a dilution of 1: 100 for 60 min, and then immunocomplexes were visualized with diaminobenzidine for 10 min and covered by a coverslip.

Techniques: Expressing